1.Beck LH Jr, Ayoub I, Caster D, et al. KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Glomerular Diseases. Am J Kidney Dis. 2023 Aug;82(2):121-175. 2.De Vriese AS,WetzelsJF, Glassock RJ, et al.Therapeutic trials in adult FSGS: lessons l...
Moreover, the United States is among the first choices for several manufacturers to conduct clinical trials. The majority of FSGS clinical trials have occurred or are currently underway in the United States, with universities and research centers heavily involved in funding the trials, which a...
clinical presentation and pathological findings on kidney biopsy is essential for sound treatment decisions in individual patients. However, it is also essential for the rational design of therapeutic trials in FSGS. Greater recognition of the pathophysiology underlying podocyte stress and damage in FSGS ...
1.Beck LH Jr, Ayoub I, Caster D, et al. KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Glomerular Diseases. Am J Kidney Dis. 2023 Aug;82(2):121-175. 2.De Vriese AS,WetzelsJF, Glassock RJ, et al.Therapeutic trials in adult FSGS: lessons l...